KER-047

N/A

Report date: 2025/03/12 13:58:12
NME

Base Information

Drug NameKER-047
Drug Alias NameKER-047TRND482477
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionActivin receptor type-1 inhibitors
TargetsActivin receptor type-1
Therapy Area/IndicationsAnemia, Iron-DeficiencyMyositis Ossificans
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaIsrael
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Center For Advancing Translational Sciences
China Registration ClassN/A

Develop Information

Active CompaniesKeros Therapeutics IncNational Center For Advancing Translational Sciences
Inactive CompaniesN/A
Active IndicationsMyositis Ossificans
Inactive IndicationsAnemia, Iron-Deficiency

Other Information

ATC CodeN/A
Related LinksN/A